Merck & Co., Inc. (MRK)

Every figure this model derived for MRK, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 3,904,000,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 7,141,000,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 36,679,000,000 AssetsCurrent 2026-06-30
current liabilities 27,731,000,000 LiabilitiesCurrent 2026-06-30
equity 41,933,000,000 StockholdersEquity 2026-06-30
interest expense 1,742,000,000 InterestExpenseNonoperating 2026-06-30
ocf 19,967,000,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 66,569,000,000 Revenues 2026-06-30
sbc 892,000,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up MRK on one particular measure came for.

RatioValue
cash operating margin16.65
current ratio1.32
current ratio reported1.32
dilution pct-1.34
ev ebit59.51
ev owner earnings27.4
ev sales6.24
fcf margin24.13
growth cv0.86
interest cover4.01
net debt ebitda4.59
operating margin10.49
owner earnings margin22.79
revenue growth4.64
revenue growth per share6.06
roic6.22
rule of 4015.13
sbc pct revenue1.34

What to be careful about

What this model itself distrusts about MRK's figures. Written by the derivation as it ran, not added afterwards.